Clinical Trial Update: Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System [NA]

View source ↗

Summary

A completed clinical trial evaluated the safety of the Advanced Hybrid Closed Loop (AHCL) System for Type 1 Diabetes Mellitus, and results were posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Advanced Hybrid Closed Loop (AHCL) System

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2022-04-08